Compound Radar

The Chemours Company (CC) Stock Analysis

Price $15.45
Market cap $2.33B
Next earnings Nov 5, 2026
Entry status Wait

Last updated Sep 8, 2026

Health Check

Last analyzed Sep 7, 2026

42
42/100 Avoid
  • Financial Health 30
  • Profitability 45
  • Business Quality 60
  • Balance Sheet 30
  • Cash Flow 45

Why this rating?

Health 42/100 — Avoid

Strongest Business Quality 60/100
Softest Balance Sheet 30/100
Wait

Entry timing is weak right now. Quality may be fine; the setup is not.

Company overview

The Chemours Company (CC) is a Specialty Chemicals company in the Basic Materials sector. Compound Radar rates The Chemours Company 42/100 (Avoid) due to solid business quality, elevated leverage, and attractive valuation.

Investment profile

  • Quality Moderate
  • Growth Soft
  • Balance Sheet Stretched
  • Valuation Attractive

Financial highlights

Valuation

  • Forward P/E 8.01
  • PEG 1.6
  • EV/Revenue 0.99

Profitability

  • Revenue Growth -1.5%
  • Gross Margin 15.4%
  • Operating Margin 1.1%
  • Net Margin -5.2%
  • ROE -319.4%

Financial strength

  • Cash $671.00M
  • Debt $4.12B
  • Net Cash $-3.45B
  • Free Cash Flow $51.00M
  • Current Ratio 1.66

Similar companies

Peers in Specialty Chemicals, ranked by Financial Health.

Company Ticker
Price Current price

Latest quoted price for the name. Helps anchor the setup in today’s market level.

Health Entry

View all in Specialty Chemicals →

FAQ

How Compound Radar scores and tracks The Chemours Company (CC).

View Methodology & FAQ →